MEK5/ERK5 pathway: the first fifteen years. 2012

Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112, USA.

While conventional MAP kinase pathways are one of the most highly studied signal transduction molecules, less is known about the MEK5 signaling pathway. This pathway has been shown to play a role in normal cell growth cycles, survival and differentiation. The MEK5 pathway is also believed to mediate the effects of a number of oncogenes. MEK5 is the upstream activator of ERK5 in many epithelial cells. Activation of the MEK-MAPK pathway is a frequent event in malignant tumor formation and contributes to chemoresistance and anti-apoptotic signaling. This pathway may be involved in a number of more aggressive, metastatic varieties of cancer due to its role in cell survival, proliferation and EMT transitioning. Further study of this pathway may lead to new prognostic factors and new drug targets to combat more aggressive forms of cancer.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D048054 Mitogen-Activated Protein Kinase 7 A 110-kDa extracellular signal-regulated MAP kinase that is activated in response to cellular stress and by GROWTH FACTOR RECEPTORS-mediated pathways. Extracellular Signal-Regulated Kinase 5,BMK1 Kinase,Big MAP Kinase 1,ERK5 Kinase,MAPK7 Mitogen-Activated Protein Kinase,Mitogen-Activated Protein Kinase 7 Isoform 1,Mitogen-Activated Protein Kinase 7 Isoform 2,Extracellular Signal Regulated Kinase 5,Kinase, BMK1,Kinase, ERK5,MAPK7 Mitogen Activated Protein Kinase,Mitogen Activated Protein Kinase 7,Mitogen Activated Protein Kinase 7 Isoform 1,Mitogen Activated Protein Kinase 7 Isoform 2
D048671 MAP Kinase Kinase 5 A mitogen-activated protein kinase kinase with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 7. MAP2K5 Protein,MAPK-ERK Kinase 5,MAPKK-5 Protein Kinase,MAPKK5 Protein Kinase,Mitogen-Activated Protein Kinase Kinase 5,MAPK ERK Kinase 5,MAPKK 5 Protein Kinase,Mitogen Activated Protein Kinase Kinase 5
D058750 Epithelial-Mesenchymal Transition Phenotypic changes of EPITHELIAL CELLS to MESENCHYME type, which increase cell mobility critical in many developmental processes such as NEURAL TUBE development. NEOPLASM METASTASIS and DISEASE PROGRESSION may also induce this transition. Epithelial-Mesenchymal Transformation,Epithelial Mesenchymal Transformation,Epithelial Mesenchymal Transition,Transformation, Epithelial-Mesenchymal,Transition, Epithelial-Mesenchymal
D020935 MAP Kinase Signaling System An intracellular signaling system involving the mitogen-activated protein kinase cascades (three-membered protein kinase cascades). Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; (MAPKKKs). Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs). The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK (extracellular signal-regulated kinase) pathway, the SAPK/JNK (stress-activated protein kinase/c-jun kinase) pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade. MAP Kinase Cascade,MAP Kinase Module,MAP Kinase Signaling Cascade,MAP Kinase Signaling Pathway,MAP Kinase Signaling Pathways,ERK Pathway,ERK Signal Tranduction Pathway,ERK1 and ERK2 Pathway,ERK1-2 Pathway,JNK Pathway,JNK Signaling Pathway,MAP Kinase Modules,MAP Kinase Signaling Cascades,MEK-ERK Pathway,p38 Kinase Pathway,p38 Kinase Signaling Pathway,Cascade, MAP Kinase,ERK Pathways,ERK1 2 Pathway,ERK1-2 Pathways,JNK Pathways,JNK Signaling Pathways,Kinase Cascade, MAP,Kinase Pathway, p38,Kinase Pathways, p38,MAP Kinase Cascades,MEK ERK Pathway,MEK-ERK Pathways,Module, MAP Kinase,Pathway, ERK,Pathway, ERK1-2,Pathway, JNK,Pathway, JNK Signaling,Pathway, MEK-ERK,Pathway, p38 Kinase,Pathways, ERK,Pathways, ERK1-2,Pathways, JNK,Pathways, JNK Signaling,Pathways, MEK-ERK,Pathways, p38 Kinase,Signaling Pathway, JNK,Signaling Pathways, JNK,p38 Kinase Pathways

Related Publications

Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
July 2021, International journal of molecular sciences,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
December 2008, Biochemical and biophysical research communications,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
July 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
April 2020, Trends in molecular medicine,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
April 2023, Cells,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
April 2014, Connective tissue research,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
July 2008, The EMBO journal,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
April 2017, Cancer letters,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
October 2016, Drug discovery today,
Barbara A Drew, and Matthew E Burow, and Barbara S Beckman
March 2003, Genes to cells : devoted to molecular & cellular mechanisms,
Copied contents to your clipboard!